We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Pevion Biotech and CEVEC Pharmaceuticals Sign Exclusive License Option Agreement

News   May 26, 2010

 
Pevion Biotech and CEVEC Pharmaceuticals Sign Exclusive License Option Agreement
 
 
 

RELATED ARTICLES

Lighting Up Cancer-causing Mutations With “LumosVar”

News

y conjuring the spell “Lumos!” wizards in the mythical world of Harry Potter could light up the tip of their magic wands and illuminate their surroundings. So, too, does LumosVar, a computer program that “lights up” cancer-causing genetic Var-ients, or mutations, illuminating how physicians might best treat their patients.

READ MORE

Seeking Out Hidden Proteins in Bacteria

News

Scientists have developed a way to identify the beginning of every gene — known as a translation start site or a start codon — in bacterial cell DNA with a single experiment and, through this method, they have shown that an individual gene is capable of coding for more than one protein.

READ MORE

“Greek Goddess” Gene Linked to Increased Cellular Aging in PTSD

News

It is well known that psychiatric stress is associated with accelerated aging. Now, a new study shows that a gene mutation interacts with multiple types of psychiatric stress including post-traumatic stress disorder (PTSD), pain and sleep disturbances in association with cellular aging.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE